No press releases found.
Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q2
Seeking Alpha News (Fri, 17-Jul 9:35 AM ET)
State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "Index"), the Fund employs a sampling strategy, which means that the Fund is not required to purchase all of the securities represented in the Index. The Index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the Pharmaceuticals sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the "Select Industry Indices"), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ("GICS").
State Street SPDR S&P Pharmaceuticals ETF trades on the ARCA stock market under the symbol XPH.
As of July 17, 2026, XPH stock price climbed to $68.52 with 37,923 million shares trading.
XPH has a beta of 0.84, meaning it tends to be less sensitive to market movements. XPH has a correlation of 0.23 to the broad based SPY ETF.
XPH has a market cap of $472.81 million. This is considered a Small Cap stock.
In the last 3 years, XPH traded as high as $70.15 and as low as $34.67.
XPH has outperformed the market in the last year with a price return of +62.9% while the SPY ETF gained +20.2%. XPH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +19.4% and +2.0%, respectively, while the SPY returned +6.1% and -0.3%, respectively.
XPH support price is $66.08 and resistance is $68.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XPH shares will trade within this expected range on the day.
